Literature DB >> 22984369

Role of acetylcholine and calcium ions in three vascular contraction models: Angiotensin II, phenylephrine and caffeine.

Katarzyna Szadujkis-Szadurska1, Grzegorz Grzesk, Leszek Szadujkis-Szadurski, Marta Gajdus, Grzegorz Matusiak.   

Abstract

The aim of this study was to determine the role of acetylcholine and calcium ions in modulating the vascular contraction induced by angiotensin II (ANG II), phenylephrine (PHE) and caffeine. The study was performed on perfunded Wistar rat tail arteries. The contraction caused by ANG II, PHE and caffeine with the participation of intracellular [in free physiological salt solution (FPSS)] and extracellular [in physiological salt solution (PSS), after emptying the cellular stores] pools of calcium ions and the addition of L-NNA (NOSe inhibitor) or ODQ (GC inhibitor) was studied. Then the effect of acetylcholine on the contraction responses was analyzed. ANG II, PHE and caffeine induced an increase in perfusion pressure in PSS and FPSS. Acetylcholine reduced the contraction resulting from the presence of ANG II and PHE, but not caffeine. L-NNA and ODQ abolished the spasmolytic action of acetylcholine. Both pools of calcium ions mediated the action of ANG II and PHE, and caffeine induced the contraction with the participation of calcium released from intracellular stores. The spasmolytic effect of acetylcholine on responses stimulated by ANG II and PHE indicates the participation of nitric oxide in modulating the reactivity of the arteries on the studied agonists of the metabotropic receptors. No observed acetylcholine effect on caffeine suggests that the pathway associated with nitric oxide does not interfere with the contraction induced by the ryanodin receptor.

Entities:  

Year:  2012        PMID: 22984369      PMCID: PMC3439186          DOI: 10.3892/etm.2012.573

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  26 in total

Review 1.  Regulation of cardiac and smooth muscle Ca(2+) channels (Ca(V)1.2a,b) by protein kinases.

Authors:  K D Keef; J R Hume; J Zhong
Journal:  Am J Physiol Cell Physiol       Date:  2001-12       Impact factor: 4.249

2.  Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation.

Authors:  L Xu; J P Eu; G Meissner; J S Stamler
Journal:  Science       Date:  1998-01-09       Impact factor: 47.728

3.  NF-kappaB activation by depolarization of skeletal muscle cells depends on ryanodine and IP3 receptor-mediated calcium signals.

Authors:  Juan Antonio Valdés; Jorge Hidalgo; José Luis Galaz; Natalia Puentes; Mónica Silva; Enrique Jaimovich; M Angélica Carrasco
Journal:  Am J Physiol Cell Physiol       Date:  2007-01-10       Impact factor: 4.249

4.  Nitric oxide and thromboxane A2 modulate pulmonary pressure after ischemia and intestinal reperfusion.

Authors:  M Słupski; K Szadujkis-Szadurska; R Szadujkis-Szadurski; L Szadujkis-Szadurski; Z Włodarczyk; J Andruszkiewicz; A T Sinjab
Journal:  Transplant Proc       Date:  2006 Jan-Feb       Impact factor: 1.066

5.  Aging increases PGHS-2-dependent vasoconstriction in rat mesenteric arteries.

Authors:  K G Stewart; Y Zhang; S T Davidge
Journal:  Hypertension       Date:  2000-06       Impact factor: 10.190

6.  Heterologous desensitization of the rat tail artery contraction and inositol phosphate accumulation after in vitro exposure to phenylephrine is mediated by decreased levels of Galphaq and Galphai.

Authors:  T M Seasholtz; H Gurdal; H Y Wang; G Cai; M D Johnson; E Friedman
Journal:  J Pharmacol Exp Ther       Date:  1997-11       Impact factor: 4.030

7.  Nitric oxide selectively inhibits intracellular Ca++ release elicited by inositol trisphosphate but not caffeine in rat vascular smooth muscle.

Authors:  J Ji; C G Benishin; P K Pang
Journal:  J Pharmacol Exp Ther       Date:  1998-04       Impact factor: 4.030

8.  Nitric oxide induces airway smooth muscle cell relaxation by decreasing the frequency of agonist-induced Ca2+ oscillations.

Authors:  Jose F Perez-Zoghbi; Yan Bai; Michael J Sanderson
Journal:  J Gen Physiol       Date:  2010-03       Impact factor: 4.086

9.  Guanylate cyclase activators influence reactivity of human mesenteric superior arteries retrieved and preserved in the same conditions as transplanted kidneys.

Authors:  M Slupski; L Szadujkis-Szadurski; G Grześk; R Szadujkis-Szadurski; K Szadujkis-Szadurska; Z Wlodarczyk; M Masztalerz; I Piotrowiak; M Jasiński
Journal:  Transplant Proc       Date:  2007-06       Impact factor: 1.066

Review 10.  Endothelium-derived nitric oxide: actions and properties.

Authors:  L J Ignarro
Journal:  FASEB J       Date:  1989-01       Impact factor: 5.191

View more
  5 in total

1.  Cardiovascular effects of long-term caffeine administration in aged rats.

Authors:  S M T El Agaty; A A Seif
Journal:  Ir J Med Sci       Date:  2014-03-18       Impact factor: 1.568

2.  Effect of 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzene-sulfonamide on calcium influx in three contraction models.

Authors:  Elżbieta Grześk; Katarzyna Szadujkis-Szadurska; Michał Wiciński; Bartosz Malinowski; Thabit A Sinjab; Barbara Tejza; Maciej Pujanek; Ewa Janiszewska; Anna Kopczyńska; Grzegorz Grześk
Journal:  Biomed Rep       Date:  2015-11-10

Review 3.  Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer's disease.

Authors:  Nasimudeen R Jabir; Fayaz Rahman Khan; Shams Tabrez
Journal:  CNS Neurosci Ther       Date:  2018-05-16       Impact factor: 5.243

4.  Caffeine inhibits acetylcholinesterase, but not butyrylcholinesterase.

Authors:  Miroslav Pohanka; Petr Dobes
Journal:  Int J Mol Sci       Date:  2013-05-08       Impact factor: 5.923

5.  The Modulatory Effect of Ischemia and Reperfusion on Arginine Vasopressin-Induced Arterial Reactions.

Authors:  Katarzyna Szadujkis-Szadurska; Bartosz Malinowski; Małgorzata Piotrowska; Grzegorz Grześk; Michał Wiciński; Marta Gajdus
Journal:  Biomed Res Int       Date:  2016-08-03       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.